|
| Cistracurium Besylate EP Impurity D Basic information |
Product Name: | Cistracurium Besylate EP Impurity D | Synonyms: | Cistracurium Besylate EP Impurity D;Cisatracurium Besylate EP Impurity D;Cisatracurium EP Impurity D;(1R,2R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-(3-methoxy-3-oxopropyl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium;(1R,?2R)?-1-?[(3,?4-?dimethoxyphenyl)?methyl]?-?1,?2,?3,?4-?tetrahydro-?6,?7-?dimethoxy-?2-?(3-?methoxy-?3-?oxopropyl)?-?2-?methylisoquinolium Benzenesulfonate;Impurities of atracurium390;(1R,2R)-1-(3,4-Dimethoxybenzyl)-6,7-dimethoxy-2-(3-methoxy-3-oxopropyl)-2-methyl-1,2,3,4-tetrahydroisoquinolinium Benzenesulfonate;Cisatracurium Besilate EP Impurity D Besylate | CAS: | 1075726-88-3 | MF: | C31H39NO9S | MW: | 601.71 | EINECS: | | Product Categories: | | Mol File: | 1075726-88-3.mol | |
| Cistracurium Besylate EP Impurity D Chemical Properties |
| Cistracurium Besylate EP Impurity D Usage And Synthesis |
Uses | (1R,?2R)?-1-?[(3,?4-?dimethoxyphenyl)?methyl]?-?1,?2,?3,?4-?tetrahydro-?6,?7-?dimethoxy-?2-?(3-?methoxy-?3-?oxopropyl)?-?2-?methylisoquinolium Benzenesulfonate is one of the reactants used in process for preparation of cisatracurium compounds, which are therapeutically useful as nondepolarizing neuromuscular blocking agents. |
| Cistracurium Besylate EP Impurity D Preparation Products And Raw materials |
|